- :: Atom & Cosmos
- :: Body & Brain
- :: Earth
- :: Environment
- :: Genes & Cells
- :: Humans
- :: Life
- :: Matter & Energy
- :: Molecules
- :: Science & Society
- :: Other Topics
- :: Science News For Kids
Knocking out a liver protein in mice can reverse the damaging effects of a super-sweet diet. Diets loaded with high-fructose corn syrup wreak havoc on metabolic processes, but how fructose does its damage has been a mystery. The new study, appearing in the March 4 Cell Metabolism, identifies a possible culprit, a protein in the liver called PGC-1 beta.
The new research is “putting together things that we know and making a link,” comments Carlos Hernandez of the University of Michigan in Ann Arbor. The paper highlights the importance of PGC-1 beta in the whole process, says Hernandez, who wrote a commentary in the same issue of Cell Metabolism on the new research.
Over the past decade, high-fructose corn syrup has made its way into Western diets through soda and processed foods in ever-increasing amounts. Diets high in fructose are linked to a slew of metabolic disorders, including nonalcoholic fatty liver disease, high blood levels of triglycerides, and insulin resistance, which is tied to type 2 diabetes, says study coauthor Yoshio Nagai, a physiologist at Yale University School of Medicine. “Many people think fat is the enemy, but they don’t care about sweeteners.”
Just like humans, mice fed a high-fructose diet develop insulin resistance and fatty liver disease. But when Nagai and his colleagues reduced the levels of the PGC-1 beta protein specifically in mice’s livers and fat tissue, these mice no longer showed signs of either disease. The mice ate a very high-fructose diet and remained unscathed, the team reports.
“PCG-1 beta knockdown can reverse the effects of a high-fructose diet in the development of insulin resistance, which is, in my opinion, a very novel, important finding,” Hernandez says.
But the picture is not clear yet. Getting rid of PGC-1 beta in mice that ate a regular diet actually caused insulin resistance. “We don't know what's happening under normal diet conditions, when the lack of PGC-1 beta produces insulin resistance,” Hernandez says.
The effect may be because of PGC-1 beta’s second job — controlling the numbers of energy-producing mitochondria in cells.
Targeting PGC-1 beta may eventually be a way to prevent the insulin resistance that results from eating too much fructose, says Nagai. But he also offers an easier strategy to avoid the health problems: Eat less fructose.
Found in: Biomedicine, Body & Brain and Genes & Cells


High fructose corn syrup has the same number of calories as sugar and is handled similarly by the body.
As noted by the American Medical Association in June 2008, “Because the composition of HFCS and sucrose are so similar, particularly on absorption by the body, it appears unlikely that HFCS contributes more to obesity or other conditions than sucrose.”
There is no scientific evidence to suggest that high fructose corn syrup is responsible for diabetes. All caloric sweeteners trigger an insulin response in the body. In fact, table sugar, honey and high fructose corn syrup trigger about the same insulin release, because they contain nearly equal amounts of fructose and glucose.
Many confuse pure “fructose” with “high fructose corn syrup,” a sweetener that never contains fructose alone, but always in combination with a roughly equivalent amount of a second sugar (glucose). Recent studies that have examined pure fructose - often at abnormally high levels - have been inappropriately applied to high fructose corn syrup and have caused significant consumer confusion.
In 1983, the U.S. Food and Drug Administration formally listed high fructose corn syrup as safe for use in food and reaffirmed that decision in 1996.
Consumers can see the latest research and learn more about high fructose corn syrup at [Link was removed] .
Audrae Erickson
President
Corn Refiners Association
It's not clear that the FDA is unbiased, either. In 2006, scientists reported pressure from administration to manipulate data regarding the approval of medical devices. It begs the question: what other areas suffer from loose ethical standards?
Also, in 2006, Lester Crawford from the FDA pled guilty to conflict of interest - he held hundreds of thousands of dollars in stock issued by companies that had products regulated by the organization. Mr. Crawford was the head of the "Obesity Working Group" within the FDA while holding stock in PepsiCo - as far as recollection allows, purchases High Fructose Corn Syrup as a sweetener for its products...
Oh, and Ms. Erickson, please don't insult your own intelligence by trying to refute scientific studies - especially when you are actually advocating for the fiscal enrichment of your own profession.
Click here to read more: [Link was removed]
[Link was removed]
[Link was removed]
[Link was removed]
[Link was removed]
[Link was removed]
[Link was removed]
[Link was removed]
[Link was removed]
[Link was removed]
[Link was removed]
[Link was removed]
Please login or register to participate.